Skip to main content

Table 2 Risk of development of dnDSA in different age groups

From: Age-associated decrease in de novo donor-specific antibodies in renal transplant recipients reflects changing humoral immunity

 

Children < 10y

Adolescent 10-19y

20-29y

30-49y

50-59y

Old ≥  60y

Cumulative prevalence dnDSA

32% (6/19)

12% (3/25)

19% (5/26)

13% (15/117)

11% (11/104)

11% (12/110)

Hazard ratio, p

–

HR 0.42 p = 0.205

HR 0.52 p = 0.312

HR 0.35 p = 0.088

HR 0.18 p = 0.014

HR 0.21 p = 0.022

Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us